Pfizer Head Says 15 Drugs Headed To Japan Market Over Next Five Years
This article was originally published in PharmAsia News
Pfizer Inc. CEO Ian Read revealed his company plans to introduce 15 drugs in the Japanese market within the next five years to help make up for patent-expirations of some of the firm’s key drugs.
You may also be interested in...
Verrica got a complete response rather than approval for its drug/device combo for molluscum, but says the FDA only needs additional information on product changes for safe usage by clinicians.
COVID-19 Consumer Health Market: Germ-Blocking Nasal Spray, 99.99% Effective Sanitizer, ‘Mask’ To Moisturize Hands
Sensory Cloud’s small study showed FEND nasal solution cut by 99% exhalation of bioaerosol to block COVID-19. Global BioProtect’s hand sanitizer with proprietary antibacterial technology eliminates 45 bacteria, fungi and virus. Trilogy Labs’ solution replenishes moisture in hands irritated by sanitizers.
FDA’s latest COVID-19 warnings note fewer violative claims than identified in previous warnings to consumer health firms. One had a single noncompliant claim on its website, while another’s violations included identifying potential symptoms of COVID-19. Four men associated with a Florida church face counts of conspiracy to defraud the US and of contempt of court stemming from COVID-1 claims for a bleach solution.